GI
MLAB icon

Gradient Investments’s Mesa Laboratories MLAB Stock Holding History

Gradient Investments’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed -$210 – 1600
2023
Q4 		$210 Hold
2
– – ﹤0.01% 1694
2023
Q3 		$210 Buy
+2
New +$256 ﹤0.01% 1671

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

Gradient Investments's MLAB Position: Q1 2024 in Review

Gradient Investments sold out of Mesa Laboratories (MLAB) in Q1 2024, closing a stake of 2 shares — an estimated $210 sold.

Gradient Investments first reported a position in MLAB in Q3 2023 and held it in 2 quarters. The position peaked at $210 in Q4 2023. 155 funds tracked by Wall St. Rank hold MLAB as of Q1 2024.

  • Gradient Investments reported no remaining Mesa Laboratories position as of Q1 2024 after selling out during the quarter.
  • Gradient Investments sold 2 Mesa Laboratories shares in Q1 2024, an estimated $210.
  • Gradient Investments first reported a position in Mesa Laboratories in Q3 2023 and held it in 2 quarters.
  • Gradient Investments's Mesa Laboratories position peaked at $210 in Q4 2023.
  • 155 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.